Stock-Based Compensation Expense (Details) - Schedule of stock options vested and exercisable - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Stock Options Vested and Exercisable [Abstract]
Shares, outstanding at beginning balance		8,769,694
Weighted- average exercise price, outstanding at beginning balance		$ 1.2
Weighted- average remaining contractual term (years), outstanding at beginning balance		7 years 1 month 24 days
Aggregate intrinsic value, outstanding at beginning balance		$ 15,746,916
Shares, granted		6,842,500
Weighted- average exercise price, granted		$ 1.2
Aggregate intrinsic value, granted
Shares ,exercised		(717,041)
Weighted- average exercise price, exercised		$ 0.16
Aggregate intrinsic value, exercised		$ 1,012,175
Shares, cancelled/forfeited		(180,043)
Weighted- average exercise price, cancelled/forfeited		$ 2.77
Aggregate intrinsic value, cancelled/forfeited
Shares, outstanding at ending balance	14,715,110
Weighted- average exercise price, outstanding at ending balance	$ 1.23
Weighted- average remaining contractual term (years), outstanding at ending balance	7 years 10 months 2 days
Aggregate intrinsic value, outstanding at ending balance	$ 2,571,013
Shares, vested and expected to vest at ending balance	14,715,110
Weighted- average exercise price, vested and expected to vest at ending balance	$ 1.23
Weighted- average remaining contractual term (years), vested and expected to vest at ending balance	7 years 10 months 2 days
Aggregate intrinsic value, vested and expected to vest at ending balance	$ 2,571,013
Shares, vested and exercisable at ending balance	6,266,135
Weighted- average exercise price, vested and exercisable at ending balance	$ 0.73
Weighted- average remaining contractual term (years), vested and exercisable at ending balance	5 years 7 months 24 days
Aggregate intrinsic value, vested and exercisable at ending balance	$ 2,555,579